About 200 reports

  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, COMORBIDITIES ASSOCIATED WITH
  • Clinical Trial
  • Dementia
  • Therapy
  • World
  • Biogen Idec Inc.
  • Description

Mental illnesses can vary from anxiety and bipolar disorder to paranoia and personality disorder.

  • Mental Health
  • Pathology
  • World
  • UNIPOLAR DEPRESSION
  • Antipsychotic
  • Psychotic Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • 2.3 GLOBAL TRENDS

The size and burden of mental disorders and other disorders of the brain in Europe 2010.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Japan
  • Forecast
  • Description

disorder, Generalised anxiety disorder, Panic disorder, Post traumatic stress disorder, Attention deficit hyperactivity disorder, Bipolar disorder, Chronic fatigue syndrome, Cognitive impairment, Delirium, Dementia, Alzheimers, Dementia with lewy

  • Mental Health
  • Pathology
  • World
  • Company Overview
  • ACQUISITION
  • Healthcare
  • Pharmaceutical
  • Renal Cancer
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H1 2017
  • PIPELINE BY TAKEDA PHARMACEUTICAL COMPANY LTD, H1 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Digestive System Disorder
  • Hormone
  • Therapy
  • World
  • Gilead Sciences, Inc.
  • LEO PHARMA AND UNIVERSITY OF QUEENSLAND ENTER INTO RESEARCH AGREEMENT FOR SKIN CANCER

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Dermatological Condition
  • Healthcare
  • Pathology
  • Pharmaceutical
  • LEO Pharma A/S
  • Products and services segmentation (2017)
  • KEY STATISTICS SNAPSHOT
  • Addictions
  • Mental Health
  • Pathology
  • Psychoactive Drug Consumption
  • Canada
  • Description

disorder, Generalised anxiety disorder, Panic disorder, Post traumatic stress disorder, Attention deficit hyperactivity disorder, Bipolar disorder, Chronic fatigue syndrome, Cognitive impairment, Delirium, Dementia, Alzheimers, Dementia with lewy

  • Mental Health
  • Pathology
  • World
  • Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2016
  • Kyowa Hakko Kirin Co., Ltd.

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Hormone
  • Pharmaceutical
  • Therapy
  • Vaccine
  • Gilead Sciences, Inc.
  • Kyowa Hakko Kirin Co., Ltd.

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Antimalarials
  • Infectious Disease
  • Pharmaceutical
  • Vaccine
  • World
  • Clinical Trial profile. 500 Trial Title
  • 5. All the trials included are unique trials.
  • Clinical Trial
  • Dementia
  • Hospital
  • Neurology
  • Pharmaceutical
  • KYOWA HAKKO KIRIN CO LTD
  • bleselumab

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Monoclonal Antibody
  • Therapy
  • United States
  • World
  • Product Initiative
  • PIPELINE BY KYOWA HAKKO KIRIN CO., LTD., H2 2016
  • KYOWA HAKKO KIRIN CO., LTD.

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Chemokine
  • Hospital
  • Therapy
  • Product Initiative
  • Kyowa Hakko Kirin Co., Ltd.
  • 7.1 GOVERNMENT
  • Global Emotional Detection and Recognition Market - By End-User - Government (Military and

personality disorder and addiction.

  • Data Analytics
  • Software
  • World
  • Affectiva, Inc.
  • Emotient, Inc.
  • IO BIOTECH APS
  • PIPELINE BY IO BIOTECH APS, H1 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Cancer
  • Research And Development
  • Therapy
  • United States
  • Incyte Corporation
  • ACTIVIOMICS ENTERS INTO RESEARCH AGREEMENT WITH KYOWA HAKKO
  • ACTIVIOMICS EXTENDS RESEARCH AGREEMENT WITH KYOWA HAKKO KIRIN

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Influenza
  • Pharmaceutical
  • United Kingdom
  • hVIVO plc
  • Clinical Trial profile. 6 Trial Title
  • Prominent Drugs
  • Depression
  • Hormone
  • Therapy
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Disorder, Schizophrenia Ongoing, recruiting Phase II Interventional PF-## Yale University National Center for Advancing Translational Sciences ## Aug 2013 ## Jul 2018 ## ## ## Sodium And Chloride Dependent Glycine Transporter ## (Glyt## or Solute Carrier Family ## Member ## or SLC##A##) Inhib

  • Clinical Trial
  • Drug Discovery And Development
  • Neurology
  • Psychotic Disorder
  • World
  • AES AT ≥5% INCIDENCE IN ADULT SCHIZOPHRENIA TRIALS OF ZYPREXA
  • OTHER SCHIZOPHRENIA SPECTRUM DISORDERS, 2015
  • Antipsychotic
  • Hospital
  • Mental Health
  • Psychotic Disorder
  • Therapy
  • KYOWA HAKKO KIRIN CO LTD
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017

It specializes in age-related disorders.

  • Dementia
  • Pain Relief
  • Pharmaceutical
  • Therapy
  • Flex Pharma, Inc.
  • Clinical Trial profile. 197 Trial Title
  • Prominent Drugs
  • Addictions
  • Neurology
  • Opioid
  • Therapy
  • Alkermes plc
  • SANFORD HEALTH COMPLETES ACQUISITION OF HILLSBORO MEDICAL CENTER
  • ACQUISITION

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Health Services
  • Healthcare
  • Pharmaceutical
  • United States
  • GlobalData's company
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017
  • KYOWA HAKKO KIRIN CO LTD

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • MedImmune, LLC
  • KYOWA HAKKO KIRIN CO., LTD.
  • PIPELINE BY KYOWA HAKKO KIRIN CO., LTD., H1 2016

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Chemokine
  • Hospital
  • Therapy
  • Product Initiative
  • Kyowa Hakko Kirin Co., Ltd.
  • International Society for the Study of Fatty Acids and Lipids (ISSFAL)
  • 5. GLOBAL NUTRITIONAL LIPIDS MARKET, BY TYPE

It is also used for high blood pressure in high-risk pregnancies (eclampsia), Age-related Macular Degeneration (AMD), schizophrenia, personality disorder, cystic fibrosis, Alzheimer' s disease, depression, and diabetes.

  • OTC
  • Europe
  • North America
  • World
  • Market Size
  • Clinical Trial profile. 28 Trial Title
  • Prominent Drugs
  • Mental Health
  • Neurology
  • Psychotic Disorder
  • Therapy
  • World
  • FUJIFILM FORMS JOINT VENTURE WITH KYOWA HAKKO KIRIN

Parent Fujifilm Holdings Corporation epilepsy, behavioral or personality disorders and others.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • FUJIFILM Holdings Corporation
  • 5.1.1 CLINICAL EVALUATION
  • 7.5 EDUCATION FOR PHYSICIANS IN ORDER TO IMPROVE DIAGNOSIS RATES

DISORDERS THAT ARE REGULARLY CONSIDERED INCLUDE UNIPOLAR MAJOR DEPRESSION, SCHIZOPHRENIA SPECTRUM DISORDERS, PERSONALITY DISORDERS, DRUG MISUSE, ALCOHOL-USE DISORDERS, AND ADHD.

  • Antipsychotic
  • Bipolar Disorder
  • Mental Health
  • Pathology
  • Therapy